EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Pharmaceutical Compliance and Ethical Practices in the U.S. Market
Ask anyone whos worked inside a pharmaceutical company for more than a few years and theyll tell you compliance used to feel like paperwork something the legal department handled while everyone else focused on real work That mindset has mostly disappeared and for good reason
-
Techno Trends
Definium Therapeutics Gains FDA Breakthrough Therapy Designation for DT120
Definium Therapeutics has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation to DT orally disintegrating tablets ODT the companys investigational lysergidebased treatment for major depressive disorder MDD
-
Projects
Sandoz to Invest US$300 Million in New Biosimilar Facility in Ljubljana
Sandoz is investing approximately US million in a new biosimilar drug substance manufacturing facility in Ljubljana Slovenia The investment will expand the companys inhouse manufacturing capacity
-
Research Insights
Phycocyanobilin: A potential bioactive compound from Arthrospira platensis targeting LYN protein associated with systemic lupus erythematosus
Phycocyanobilin a bioactive compound derived from Arthrospira platensis C was investigated for its potential role in systemic lupus erythematosus SLE based on its structural similarity to bilirubin
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Evolving Trends and Strategies in Pharmaceutical Marketing: Focus on the American Market
Kate Williamson
This exploration delves into evolving trends and strategies in pharmaceutical marketing, with a focus on the dynamic American market. From digital transformation and patient-centric approaches to data...
-
2
Why Great Science Still Fails at the Regulatory Finish Line
Lakshmi
Pharmaceutical organizations are built to prove a molecule works. Regulators, at the decision point, ask something else: can it be reliably made, have the sites been verified, does the trial design su...
-
3
Adaptive Trial Designs for Oncology: Efficiency Versus Regulatory Acceptance
Lakshmi
Adaptive designs promise faster answers for cancer patients who cannot afford to wait. Regulators, once wary, are increasingly on board — but efficiency and acceptance still pull in different di...
-
4
From Miracle Drugs to Superbugs: Understanding Antimicrobial Resistance
Kate Williamson
AMR is characterized as one of the most severe threats to global health since it weakens antibiotics, antiviral drugs, antifungal drugs and antiparasitic drugs. This article is based on the developmen...
-
5
AI-Driven Trial Operations and Site Management: The AI-Powered Future of Clinical Research
Dr. Sandesh Nalawade
Clinical trial operations are undergoing a transformative shift driven by artificial intelligence (AI). AI technologies are revolutionising site selection, monitoring, and data management, enabling re...
press releasesRead more...
Lilly breaks ground in Houston, one of ten U.S. manufacturing sites announced since 2020
Eli Lilly and Company NYSE LLY broke ground today in Houston Texas one of ten US manufacturing sites and fifth location to produce domestic active pharmaceutical ingredients API
Iambic Launches Enchant v3 – Molecular Superintelligence Designed to Advance End-to-End Drug Discovery & Development
Iambic a clinicalstage life science and technology company developing novel medicines using its AIdriven platform today unveiled Enchant v the next generation of its multimodal transformer model built
Sandoz announces collaboration with mAbxience to expand patient access to life-enhancing biosimilar medicines
Sandoz announces collaboration with mAbxience to expand patient access to lifeenhancing biosimilar medicines Sandoz SIXSDZOTCQXSDZNY the global leader in affordable medicines
Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center
Kincell Bio and Cellipont Bioservices today announced the completion of their merger to form Kincellis Advanced Therapies Kincellis a USbased contract development and manufacturing organization focused on cell therapies and other advanced modalities
Events Read more...
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 02
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
LATEST NEWSRead more...
BoomRay Enters Global Licensing Agreement with Novartis for Radioligand Therapy Asset
BoomRay Pharmaceuticals has entered into an exclusive global licensing agreement with Novartis Pharma for an undisclosed preclinical radioligand therapy RLT asset
AbbVie and Iambic Collaborate to Accelerate AI-Driven Drug Discovery
AbbVie and Iambic have entered into a multiyear collaboration to accelerate the discovery and development of smallmolecule therapies with potential firstinclass and bestinclass profiles across immunology neuroscience and oncology
US FDA approves Inluriyo with Verzenio for advanced breast cancer
The US Food and Drug Administration FDA has granted full approval to Eli Lilly and Companys Inluriyo imlunestrant in combination with Verzenio abemaciclib for adults with estrogen receptorpositive ER
Amneal receives FDA approval and launches lanreotide injection
Amneal Pharmaceuticals has received approval from the US Food and Drug Administration FDA for its lanreotide injection mg mL supplied in a sterile singledose prefilled syringe
Bayer’s KERENDIA Receives FDA Approval for Chronic Kidney Disease Linked to Type 1 Diabetes
Bayers KERENDIA finerenone has received approval from the US Food and Drug Administration FDA for use in adults with chronic kidney disease CKD associated with type diabetes TD
Kincell Bio and Cellipont Bioservices Merge to Create Kincellis Advanced Therapies
Kincell Bio and Cellipont Bioservices have merged to form Kincellis Advanced Therapies creating a broader contract development and manufacturing organisation CDMO focused on advanced cell and gene therapies
